{"altmetric_id":2818187,"counts":{"readers":{"mendeley":15,"citeulike":0,"connotea":0},"total":{"posts_count":9},"twitter":{"unique_users_count":9,"unique_users":["Transplant_Doc","CIBMTR","DrMiguelPerales","NextGEN_Ltd","3NT","Mohty_EBMT","DrMvandenBrink","CancerCureNow","gottarun1000"],"posts_count":9}},"selected_quotes":["Chronic GVHD is only in CML patients associated with decreased relapse risk","Impact of cGVHD on Late Relapse and Survival #CancerNews","Anti-leukemia effects of chronic GVHD are present only in CML but not in AML, ALL or MDS","Impact of chronic graft-versus-host disease on late relapse and survival on 7489 patients aft"],"citation":{"altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Michael Boyiadzis","Mukta Arora","John Klein","Anna Hassebroek","Michael Hemmer","Alvaro Urbano-Ispizua","Joseph H Antin","Brian Bolwell","Jean-Yves Cahn","Mitchell S Cairo","Corey Cutler","Mary Flowers","Robert Gale","Roger Herzig","Luis Isola","David Jacobsohn","madan jagasia","Thomas Klumpp","Stephanie J Lee","Effie Petersdorf","Stella Santarone","Stephan Spellman","Harry C. Schouten","Leo Verdonck","John Wingard","Daniel Weisdorf","Mary Horowitz","Steven Pavletic","Boyiadzis M","Arora M","Klein J","Hassebroek A","Hemmer M","Urbano-Ispizua A","Antin JH","Bolwell B","Cahn JY","Cairo MS","Cutler C","Flowers M","Gale R","Herzig R","Isola L","Jacobsohn D","Jagasia M","Klumpp T","Lee SJ","Petersdorf E","Santarone S","Spellman S","Schouten HC","Verdonck L","Wingard J","Weisdorf D","Horowitz M","Pavletic S"],"doi":"10.1158\/1078-0432.ccr-14-0586","endpage":"2028","first_seen_on":"2014-10-28T13:07:17+00:00","funders":["nci","phs","nhlbi"],"issns":["1557-3265","1078-0432"],"issue":"9","journal":"Clinical Cancer Research","last_mentioned_on":1429247622,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/25\/1078-0432.CCR-14-0586.abstract?papetoc=","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25348512","http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/25\/1078-0432.CCR-14-0586.long","http:\/\/clincancerres.aacrjournals.org\/content\/early\/2015\/04\/15\/1078-0432.CCR-14-0586.short?rss=1"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/25\/1078-0432.CCR-14-0586.full.pdf","pmid":"25348512","pubdate":"2014-10-27T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"2020","title":"Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia","type":"article","volume":"21","mendeley_url":"http:\/\/www.mendeley.com\/research\/impact-chronic-graftversushost-disease-late-relapse-survival-7489-patients-after-myeloablative-allog"},"altmetric_score":{"score":3.85,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3.85},"context_for_score":{"all":{"total_number_of_other_articles":5005391,"mean":5.9288550146973,"rank":1088511,"this_scored_higher_than_pct":78,"this_scored_higher_than":3907070,"rank_type":"exact","sample_size":5005391,"percentile":78},"similar_age_3m":{"total_number_of_other_articles":142313,"mean":8.7349386278038,"rank":36659,"this_scored_higher_than_pct":73,"this_scored_higher_than":105252,"rank_type":"exact","sample_size":142313,"percentile":73},"this_journal":{"total_number_of_other_articles":4246,"mean":4.0694058892815,"rank":834,"this_scored_higher_than_pct":80,"this_scored_higher_than":3404,"rank_type":"exact","sample_size":4246,"percentile":80},"similar_age_this_journal_3m":{"total_number_of_other_articles":143,"mean":8.6402957746479,"rank":37,"this_scored_higher_than_pct":74,"this_scored_higher_than":106,"rank_type":"exact","sample_size":143,"percentile":74}}},"demographics":{"poster_types":{"member_of_the_public":6,"researcher":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Scientists":2,"Members of the public":6,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Unspecified":1,"Librarian":1,"Student  > Doctoral Student":1,"Researcher":2,"Student  > Ph. D. Student":2,"Other":3,"Student  > Master":3,"Professor":2},"by_discipline":{"Engineering":1,"Medicine and Dentistry":8,"Chemistry":1,"Social Sciences":1,"Agricultural and Biological Sciences":2,"Unspecified":2}}},"geo":{"twitter":{"US":2},"mendeley":{"NL":1,"US":2}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/Transplant_Doc\/status\/527829605407662080","license":"datasift","citation_ids":[2818187],"posted_on":"2014-10-30T14:29:19+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3416},"tweet_id":"527829605407662080"},{"url":"https:\/\/twitter.com\/CIBMTR\/status\/527834865903751168","license":"datasift","rt":["DrMiguelPerales"],"citation_ids":[2818187],"posted_on":"2014-10-30T14:50:13+00:00","author":{"name":"CIBMTR","url":"http:\/\/www.cibmtr.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/449599390663991297\/jvk6iTvy_normal.png","description":"Research organization, collaborating with the global scientific community in an effort to increase survival and enrich quality of life for patients needing BMT.","id_on_source":"CIBMTR","tweeter_id":"409520224","geo":{"lt":43.04946,"ln":-88.00759,"country":"US"},"followers":1529},"tweet_id":"527834865903751168"},{"url":"https:\/\/twitter.com\/DrMiguelPerales\/status\/527834731489280000","license":"datasift","citation_ids":[2818187],"posted_on":"2014-10-30T14:49:41+00:00","author":{"name":"Miguel Perales M.D.","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/miguel-angel-perales","image":"https:\/\/pbs.twimg.com\/profile_images\/420287281832787968\/QqvGIWhX_normal.jpeg","description":"Oncologist @sloan_kettering. Stem cell transplantation Lymphoma Leukemia MDS Myeloma Immunotherapy Vaccines. @BeTheMatch & @ASBMT Board Member. Tweets mine.","id_on_source":"DrMiguelPerales","tweeter_id":"1407780158","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":6642},"tweet_id":"527834731489280000"},{"url":"https:\/\/twitter.com\/NextGEN_Ltd\/status\/530113000590835713","license":"datasift","rt":["DrMvandenBrink"],"citation_ids":[2818187],"posted_on":"2014-11-05T21:42:43+00:00","author":{"name":"\u0412\u043b\u0430\u0434","image":"https:\/\/pbs.twimg.com\/profile_images\/2342353963\/irjhyyc7ed67fugjx2fk_normal.jpeg","id_on_source":"NextGEN_Ltd","tweeter_id":"443359139","geo":{"lt":null,"ln":null},"followers":89},"tweet_id":"530113000590835713"},{"url":"https:\/\/twitter.com\/3NT\/status\/530153957578899458","license":"datasift","rt":["DrMvandenBrink"],"citation_ids":[2818187],"posted_on":"2014-11-06T00:25:27+00:00","author":{"name":"Pieter Droppert","url":"http:\/\/biotechstrategyblog.com","image":"https:\/\/pbs.twimg.com\/profile_images\/903010154731458560\/9e7JONNJ_normal.jpg","description":"I produce @TargetsPodcast & write on @BiotechStrategy about cancer research","id_on_source":"3NT","tweeter_id":"228845995","geo":{"lt":null,"ln":null},"followers":1371},"tweet_id":"530153957578899458"},{"url":"https:\/\/twitter.com\/Mohty_EBMT\/status\/530124239882711040","license":"datasift","rt":["DrMvandenBrink"],"citation_ids":[2818187],"posted_on":"2014-11-05T22:27:22+00:00","author":{"name":"Mohamad Mohty","url":"http:\/\/www.ebmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/480924346299346944\/OOXDgK3a_normal.jpeg","description":"Professor of Hematology and president of the European society for Blood and Marrrow Transplantation (EBMT)","id_on_source":"Mohty_EBMT","tweeter_id":"2626263112","geo":{"lt":null,"ln":null},"followers":2756},"tweet_id":"530124239882711040"},{"url":"https:\/\/twitter.com\/DrMvandenBrink\/status\/530112794499117056","license":"datasift","citation_ids":[2818187],"posted_on":"2014-11-05T21:41:53+00:00","author":{"name":"Marcel van den Brink","image":"https:\/\/pbs.twimg.com\/profile_images\/3380100954\/70e6d478a7eb705e9921bf5d039e88c5_normal.jpeg","description":"Head of the Division of Hematologic Oncology at MSKCC. Tweets and opinions are my own. http:\/\/www.mskcc.org\/research\/lab\/marcel-van-den-brink","id_on_source":"DrMvandenBrink","tweeter_id":"1267928143","geo":{"lt":null,"ln":null},"followers":2898},"tweet_id":"530112794499117056"},{"url":"https:\/\/twitter.com\/CancerCureNow\/status\/527083938494574592","license":"datasift","citation_ids":[2818187],"posted_on":"2014-10-28T13:06:18+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8351},"tweet_id":"527083938494574592"},{"url":"https:\/\/twitter.com\/gottarun1000\/status\/588933330340556800","license":"datasift","citation_ids":[2818187],"posted_on":"2015-04-17T05:13:42+00:00","author":{"name":"Scott Werntz","url":"http:\/\/www.miraclemiles.me","image":"http:\/\/pbs.twimg.com\/profile_images\/3322174087\/7bcb548396c7d0d27f93007cd3900f58_normal.jpeg","description":"I am running 1000 miles in 1 year in honor of David Hatfield to raise $100,000 for Lymphoma and Leukemia Society. Tune in regularly for breaking news!","id_on_source":"gottarun1000","tweeter_id":"1217238458","followers":95},"tweet_id":"588933330340556800"}]}}